1998
DOI: 10.1002/(sici)1097-0215(19980717)77:2<251::aid-ijc14>3.3.co;2-o
|View full text |Cite
|
Sign up to set email alerts
|

Anti‐CD3‐based bispecific antibody designed for therapy of human B‐cell malignancy can induce T‐cell activation by antigen‐dependent and antigen‐independent mechanisms

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 1 publication
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?